The Timing Hypothesis: HRT and Long-Term Heart Health
Understand the 'Window of Opportunity' for hormone therapy and its role in preventing cardiovascular disease and dementia.
Verified against Clinical Guidelines
This article was developed and verified against current clinical standards from NAMS, BMS, and the STRAW+10 staging framework.
For decades, confusion surrounding the Women's Health Initiative (WHI) study led many to fear HRT. Modern 'Timing Hypothesis' research suggests that starting HRT within 10 years of menopause (the window of opportunity) can actually be cardioprotective.
The Cardiovascular Bridge
Estrogen receptors are located throughout the vascular system. When replacement is started early, it helps maintain endothelial function and prevents the buildup of plaque. Citing the KEEPS trial as a cornerstone, we explain how transdermal estradiol supports metabolic and heart health.
Neuroprotection & Quality of Life
Research suggests that the same 'window' applies to cognitive health. While HRT is not a cure for dementia, the neuroprotective effects of estradiol are most potent when initiated during the transition phase.
References & Sources
Next step
Explore the HRT Research Hub
Deep dive into the ELITE and KEEPS trials and what they mean for your longevity.
Open HRT research →Keep reading
- What to Track Before an HRT Conversation
Before discussing menopausal hormone therapy, track the symptoms that matter, your contraindication history, and what “success” would look like for you.
- Perimenopause at Work: Reasonable Adjustments That Help
Perimenopause at work: symptoms can disrupt focus, temperature control, and energy. A guide to adjustments, how to raise the conversation, and your rights.
- Perimenopause and Bone Loss: What to Know About Osteoporosis
Bone loss accelerates in perimenopause before symptoms appear. Learn why, what a DEXA scan tells you, and how to protect your skeleton now.